CFTR and cystic fibrosis: Since many other nutraceuticals have demonstrated to alleviate cystic fibrosis symptoms by different mechanisms of action [26,27,28,29], we have attempted a computational drug repositioning analysis to identify small compounds able to accommodate in the large lumacaftor interaction region of F508del-CFTR in such a way to synergize with the drug.